-

Fellow Health to Present Five Studies at the American Urological Association 2026 Annual Meeting

Research spans post-vasectomy semen analysis, metabolic and socioeconomic drivers of male fertility, and fertility preservation in young cancer patients, drawing on one of the largest U.S. cohorts of mail-in semen analyses ever assembled

SAN LEANDRO, Calif.--(BUSINESS WIRE)--Fellow Health, a leading company focused on advancing male reproductive health through patient-centric testing solutions, today announced that data from five studies leveraging its mail-in semen analysis platform will be presented at the American Urological Association (AUA) 2026 Annual Meeting, taking place May 15–18, 2026, in Washington, D.C. The studies draw on Fellow Health’s nationwide network of more than 3,000 fertility and urology practices.

One of the studies, Poor Metabolic Health Associated with Lower Semen Quality and Higher IVF Rates: Analysis of 25,000 US Men, was selected by the AUA to be highlighted in its press release recognizing the quality of research presented at this year’s meeting.

“Many men are reluctant to set foot in a fertility clinic. By bringing the lab to them, we’re capturing a population that male reproductive medicine hasn’t been able to study before,” said James F. Smith, MD, MS, Chief Medical Officer and NYS Laboratory Director at Fellow Health. “We’ve been able to answer questions about vasectomy outcomes, the metabolic and socioeconomic factors that shape fertility, and how cancer patients are counseled on preserving their reproductive future.”

Presentation Schedule

PD05-01Socioeconomic Deprivation and Male Fertility: Decreasing Prosperity Associated with Lower Semen Parameters in a Nationwide Cohort

Presenter: Juan Varela, University of Florida — Friday, May 15, 1:00–1:08 PM, Room 206

PD05-06Real-World Results of Post-Vasectomy Semen Analysis: A Large National Sample of Over 100,000 Men

Presenter: Tristan Nicholson, MD, University of Washington — Friday, May 15, 1:40–1:48 PM, Room 206

PD05-13Poor Metabolic Health Associated with Lower Semen Quality and Higher IVF Rates: Analysis of 25,000 US Men

Presenter: Denise Asafu-Adjei, MD, University of Chicago — Friday, May 15, 2:36–2:44 PM, Room 206

IP52-08Influence of Age on the Successful Clearance of Sperm in Post-Vasectomy Semen Analysis

Presenter: David Shin, MD, Hackensack Meridian School of Medicine — Sunday, May 17, 7:00–9:00 AM, Room 146C

IP64-19Specialty-Specific Approaches to Fertility Preservation in Adolescent and Young Adult Cancer Care

Presenter: Elizabeth Gurt Lynch, MD, UCSF Department of Urology — Sunday, May 17, 1:00–3:00 PM, Room 146C

About Fellow Health

Founded in 2018, Fellow Health is a leading company dedicated to advancing male reproductive health through innovative and comprehensive mail-in testing solutions. The company partners with more than 3,000 top clinical practices, processing over 400 patient samples daily through its CLIA-certified lab, and is the only mail-in fertility test with peer-reviewed validation data. Fellow Health has secured funding from leading life sciences and technology investors, including 5AM Ventures, Forest Road, Labcorp Venture Fund, Genoa Ventures, and Mantis Venture Capital.

Contacts

Media Contact:
media@meetfellow.com

Fellow Health

Details
Headquarters: San Leandro, California
CEO: Brian Hogan
Employees: 56
Organization: PRI

Release Versions

Contacts

Media Contact:
media@meetfellow.com

More News From Fellow Health

Fellow Health Appoints Industry Executive Paul Kappelman as Independent Chairman of the Board

SAN LEANDRO, Calif.--(BUSINESS WIRE)--Fellow Health, a leading company focused on advancing male reproductive health through patient-centric testing solutions, today announced that industry executive and private equity advisor Paul Kappelman has been appointed Independent Chairman of the Board. Mr. Kappelman brings more than 30 years of healthcare leadership experience, including deep expertise in fertility care, to support Fellow Health in its next phase of growth. Mr. Kappelman previously ser...

Fellow Health Joins Progyny Network to Support Men’s Health Fertility Screening with Mail-In Semen Analysis for Fertility Care

SAN LEANDRO, Calif.--(BUSINESS WIRE)--Fellow Health, a leading company focused on advancing male reproductive health through patient-centric testing solutions, today announced it is joining the Progyny network to support the growing need for semen analysis as a critical step in the fertility care journey. Fellow Health’s mail-in semen analysis will be a covered benefit for eligible Progyny members, giving patients access to convenient, at-home testing with results equivalent to traditional in-c...

Fellow Health Announces New York State Approval for Its Lab & Post-vasectomy Semen Analysis Kit

SAN LEANDRO, Calif.--(BUSINESS WIRE)--Fellow Health, a leading company focused on advancing male reproductive health through patient-centric testing solutions, today announced that it received a high-complexity laboratory permit from the New York State Department of Health (NYSDOH) Clinical Laboratory Evaluation Program (CLEP) along with approval for its post-vasectomy semen analysis (PVSA). This milestone allows Fellow Health to offer its validated PVSA test in New York. Roughly 500,000 vasect...
Back to Newsroom